If you need more lookups,
subscriptions start at $34 USD/month.
Bernhard Ehmer Location
Dreieich, HE, DE
Bernhard Ehmer Work
Chairman of the Board of Directors @ (May 2022 - Present)
CEO @ (January 2015 - May 2019)
Past President @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (January 2013 - October 2014)
President @ ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company (November 2009 - December 2012)
Managing Director @ ImClone Systems International (May 2008 - November 2009)
CEO @ (May 2007 - May 2008)
CEO @ Biopheresis GmbH (May 2006 - May 2007)
VP Therapeutic Area Oncology @ (October 1998 - February 2006)
VP Medical Affairs; Head regionla office Asia @ (May 1986 - August 1998)
Bernhard Ehmer Education
Ludwig-Maximilians-Universität München
Heidelberg University
Doctor of Medicine (MD) (Medicine)
Bernhard Ehmer Skills
Oncology
Drug Development
Biotechnology
Biopharmaceuticals
Clinical Development
Pharmaceutical Industry
Clinical Trials
Medical Affairs
Technology Transfer
Drug Discovery
CRO
Lifesciences
Vaccines
GCP
Immunology
CTMS
Cancer
Regulatory Affairs
FDA
Life Sciences
Validation
GMP
Sop
21 CFR Part 11
Sales
Clinical Research
Healthcare
Microsoft Excel
Business Strategy
Bernhard Ehmer Summary
Bernhard Ehmer, based in Dreieich, HE, DE, is currently a Chairman of the Board of Directors at Biotest AG. Bernhard Ehmer brings experience from previous roles at Biotest AG, ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company and ImClone Systems International. Bernhard Ehmer holds a Ludwig-Maximilians-Universität München. With a robust skill set that includes Oncology, Drug Development, Biotechnology, Biopharmaceuticals, Clinical Development and more. Bernhard Ehmer has 1 emails on RocketReach.
Looking for a different Bernhard Ehmer?
Find contact details for 700 million professionals.